Clinical Trials Browser

Phase 1/2 × Locally Advanced or Metastatic Solid Tumors × tislelizumab × Clear all

NCT05699811 2023-04-28

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors